Knowledge of germline BRCA1 or BRCA2 variant status results in increased breast cancer surveillance, earlier breast cancer diagnosis, increased gynecological cancer surveillance, and prevention of fallopian tube and ovarian cancers [7]. This evidence concerns the gene BRCA1 and ovarian carcinoma.